Annovis Bio, Inc. — Investor Relations & Filings
Filings indexed
290
across all filing types
Latest filing
2026-05-20
Regulatory Filings
Country
US
United States of America
Listing
US
ANVS
Annovis Bio, Inc. is a clinical-stage drug platform company that develops therapies for neurodegenerative diseases. The company's primary focus is on conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD). Its lead product candidate, buntanetap, is a translational inhibitor designed to halt the death of nerve cells by targeting the synthesis of multiple neurotoxic proteins. The company's therapeutic approach aims to restore nerve cell function, with the goal of improving cognitive and motor abilities in patients suffering from neurodegeneration.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 46691547 | FORM 8-K | 2026-05-20 | English | ||
| 46691545 | 424B5 | 2026-05-20 | English | ||
| 46559848 | 424B5 | 2026-05-19 | English | ||
| 46362836 | 10-Q | 2026-05-15 | English | ||
| 46361439 | FORM 8-K | 2026-05-15 | English | ||
| 33940010 | 424B5 - Annovis Bio, Inc. (0001477845) (Filer) | 2026-04-09 | English | ||
| 33043098 | 8-K - Annovis Bio, Inc. (0001477845) (Filer) | 2026-03-25 | English | ||
| 30034997 | 8-K Filing | 2026-02-12 | English | ||
| 30034999 | 8-K Filing | 2026-01-28 | English | ||
|
2025
6 filings
| |||||
| 12326726 | OWNERSHIP DOCUMENT | 2025-12-08 | English | ||
| 12326730 | OWNERSHIP DOCUMENT | 2025-11-25 | English | ||
| 12326728 | OWNERSHIP DOCUMENT | 2025-11-25 | English | ||
| 12326727 | OWNERSHIP DOCUMENT | 2025-11-21 | English | ||
| 12326729 | OWNERSHIP DOCUMENT | 2025-11-18 | English | ||
| 12326731 | 8-K | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Clinical-stage pharma company developing PP2A inhibitors to…
|
LIXT | US | Professional, scientific and te… |
|
Lunai Bioworks Inc.
Pre-clinical biotech company using AI for drug discovery an…
|
RENB | US | Professional, scientific and te… |
|
LYSOGENE
A former clinical-stage biotech that developed gene therapi…
|
LYS | FR | Professional, scientific and te… |
|
MaaT Pharma
A clinical-stage biotech developing microbiome-based therap…
|
MAAT | FR | Professional, scientific and te… |
|
Many Bright Ideas Technologies Inc.
Acquires, develops, and commercializes IP, emphasizing alte…
|
MBI.H | CA | Professional, scientific and te… |
|
MapLight Therapeutics, Inc.
Develops targeted therapies for CNS disorders using circuit…
|
MPLT | US | Professional, scientific and te… |
|
Marvel Biosciences Corp.
Developing transformative treatments for complex neurologic…
|
MRVL | CA | Professional, scientific and te… |
|
Matinas BioPharma Holdings, Inc.
Biopharma firm developing therapeutics using its Lipid Nano…
|
MTNB | US | Professional, scientific and te… |
|
Matricelf Ltd.
Develops autologous, patient-specific tissue implants for r…
|
MTLF | IL | Professional, scientific and te… |
|
MAXCYTE, INC.
A cell-engineering company with a platform for developing c…
|
MXCT | US | Professional, scientific and te… |
Annovis Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34695/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34695 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34695 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34695 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34695}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Annovis Bio, Inc. (id: 34695)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.